Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
| Status: | Withdrawn |
|---|---|
| Conditions: | Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 95 |
| Updated: | 9/12/2018 |
| Start Date: | November 2007 |
| End Date: | September 2009 |
The purpose of this study is to compare the treatment of skin growths called actinic
keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other
conventionally used FDA-approved agents such as cryotherapy, Imiquimod, or 5-fluorouracil
(5-FU).
keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other
conventionally used FDA-approved agents such as cryotherapy, Imiquimod, or 5-fluorouracil
(5-FU).
Inclusion Criteria:
- 18-95 years old
- Diagnosied with actinic keratoses.
Exclusion Criteria:
- Patients who have had Isotretinoin therapy less that 1 year prior to screening.
- Patients who have an adverse reaction to light exposure (for example photo-
exacerbated seizures).
- History of porphyria
We found this trial at
1
site
University of Chicago One of the world's premier academic and research institutions, the University of...
Click here to add this to my saved trials
